NTRR
NEUTRA CORP.Company Information
- Company Name
- NEUTRA CORP.
- CIK
- CIK0001512886
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- NTRR: OTC
- Fiscal Year End
- January 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2833
- SIC Description
- Medicinal Chemicals & Botanical Products
- Ticker
- NTRR
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2023-12-15
- Price on filing date
- —
- 1-month reaction
- -25.00%
- 3-month reaction
- -12.50%
Balance Sheet
Values in millions ($)| Line item | 2023-10-31 | 2023-07-31 | 2023-04-30 | 2023-01-31 | 2022-10-31 | 2022-07-31 | 2022-04-30 | 2022-01-31 | 2021-10-31 | 2021-07-31 | 2021-04-30 | 2021-01-31 | 2020-10-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deposit Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | |||||||||||||||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Current | 0 | - | - | - | - | - | - | - | - | 0 | 0 | 0 | - | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities And Stockholders Equity | |||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable Related Parties Current | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | |||||||||||||||||||
| Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Dividends Payable Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Other Liabilities Current | - | - | - | - | - | - | 0 | - | - | - | - | - | - | ||||||
| Interest Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Long Term Notes Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Mezzanine Equity | |||||||||||||||||||
| Common Stock Value | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | ||||||
Stockholders Equity | |||||||||||||||||||
| Additional Paid In Capital Common Stock | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | ||||||
| Stockholders Equity | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | ||||||
| Preferred Stock Shares Subscribed But Unissued Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -12 | -12 | -12 | -11 | -11 | -11 | -11 | -11 | -11 | -10 | -10 | -10 | -10 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Issued | 2,918 | 2,918 | 2,918 | 2,744 | 2,301 | 2,301 | 2,208 | 1,782 | 1,677 | 1,563 | 1,519 | 1,493 | 1,384 | ||||||
| Shares Outstanding | 2,918 | 2,918 | 2,918 | 2,744 | 2,301 | 2,301 | 2,208 | 1,782 | 1,677 | 1,563 | 1,519 | 1,493 | 1,384 | ||||||
| Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialNEUTRA CORP. (NTRR) — SEC Financial Statements & Analysis
NEUTRA CORP. (NTRR) is a medicinal chemicals & botanical products company, incorporated in WY. NEUTRA CORP. trades on OTC as: NTRR. NEUTRA CORP. (NTRR)'s most recent SEC filing is a Form 10-Q for the period ended 2023-10-31, filed with the SEC on 2023-12-15. Based on that filing, NEUTRA CORP. carries a market cap of $875.37K, a P/E ratio of -1.85x, a P/B ratio of -0.94x, a P/S ratio of 50.32x, an enterprise value of $928.83K, and an EV/EBITDA multiple of -4.84x. On profitability, it posts a gross margin of 46.15%, an operating margin of -1457.11%, a net margin of -2723.64%, a Return on Equity (ROE) of 43.08%, and a Return on Assets (ROA) of -758.70%. Per share, it reports EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -82.68% year-over-year, net income growth of 2.52% year-over-year, and EPS growth of -19.16% year-over-year. On the balance sheet, it maintains a current ratio of 0.02x, a quick ratio of 0.00x, working capital of $-889.43K, a debt-to-equity ratio of -1.03x, a debt ratio of 35.74, an interest coverage ratio of -14.07x, free cash flow of $-9.76K (TTM), and net debt of $53.46K. Figures sourced from SEC EDGAR.
- Market Cap
- $875.37K
- P/E TTM
- -1.85x
- EPS TTM
- $-0.00
- P/B TTM
- -0.94x
- ROE TTM
- 43.08%
- ROA TTM
- -758.70%
- Debt To Equity
- -1.03x
- Free Cash Flow TTM
- $-9.76K
- Net Revenue TTM Growth 1Y
- -82.68%
Data as of 2023-10-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is NEUTRA CORP. in?
NEUTRA CORP. (NTRR) operates in the Medicinal Chemicals & Botanical Products industry.
What exchange does NTRR trade on?
NEUTRA CORP. (NTRR) trades on the OTC.
Where is NEUTRA CORP. incorporated?
NEUTRA CORP. is incorporated in WY.
When was NEUTRA CORP. (NTRR)'s most recent SEC filing?
NEUTRA CORP. (NTRR)'s most recent SEC filing is a Form 10-Q for the period ended 2023-10-31, filed with the SEC on 2023-12-15.
What is NTRR's market cap?
NEUTRA CORP. (NTRR) has a market capitalization of $875.37K as of 2023-10-31.
What is NTRR's EPS (earnings per share)?
NEUTRA CORP. (NTRR)'s trailing twelve month EPS is $-0.00 as of 2023-10-31.
What is NTRR's ROE (return on equity)?
NEUTRA CORP. (NTRR)'s trailing twelve month Return on Equity (ROE) is 43.08% as of 2023-10-31.
What is NTRR's ROA (return on assets)?
NEUTRA CORP. (NTRR)'s trailing twelve month Return on Assets (ROA) is -758.70% as of 2023-10-31.
What is NTRR's EV/EBITDA?
NEUTRA CORP. (NTRR)'s trailing twelve month EV/EBITDA is -4.84x as of 2023-10-31.